Curcuminoid compounds show promise against COVID-19 in neuronal cells

FHS
May 14, 2024
11:18 am

The effects of curcumin and curcuminoids on a human neuroblastoma cell line (SH-SY5Y) infected with SARS-CoV-2.

IPO vs. Acquisition for Life Science Companies: Expert Q&A

Taylor Wirth, Partner at Barnes & Thornburg Life science companies, particularly those heavily invested in research and development, often face critical funding decisions. Should they

November 13, 2024

Flagship launches AI-powered biologics biotech with $50M backing

Flagship Pioneering has unveiled a new biotech that’s on a mission to build a new class of biologics with the help of AI. Abiologics, which

July 24, 2024

Specialist support helps new moms with severe mental illness reduce relapse risk

New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London, and in partnership with the University of Exeter and the

January 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.